---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-036630"
form_type: "8-K"
ticker: "AYTU"
cik: "0001385818"
company_name: "AYTU BIOPHARMA, INC"
filed_at: "2024-12-04T23:59:59+00:00"
generated_at: "2026-05-29T08:29:52.516874+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Aytu settles derivative shareholder suit; court hearing Jan 13, 2025

## Summary
- Settlement approval hearing scheduled for January 13, 2025 in Delaware Chancery Court.
- Aytu to pay $250,000 in attorneys' fees and $5,000 service award to plaintiff.
- Governance enhancements include new independent board member, CEO/Chair separation, enhanced insider trading oversight.
- D&O defendants released; claims against Armistice defendants preserved with Aytu remaining neutral.

## SEC filing metadata
- accession: 0001437749-24-036630
- form_type: 8-K
- ticker: AYTU
- cik: 0001385818
- company_name: AYTU BIOPHARMA, INC
- filed_at: 2024-12-04T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1385818/000143774924036630/0001437749-24-036630-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1385818/000143774924036630/aytu20241203_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-036630
- JSON: https://secwatch.observer/filing/0001437749-24-036630.json
- Plain text: https://secwatch.observer/filing/0001437749-24-036630.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.